Uropathogenic Escherichia coli (UPEC) that hides its identity: features of LC2 and EC73 strains from recurrent urinary tract infections
Abstract
Background: Uropathogenic Escherichia coli (UPEC) strains are the major causative agents of human urinary tract infections (UTIs). Many patients who develop UTIs will experience a recurrent UTI (RUTI) within 6 months despite antibiotic-mediated clearance of the initial infection. A significant proportion of RUTIs are caused by E. coli identical to the original strain. UPEC employs several strategies to adhere, colonize, and persist within the bladder niche. Knowledge about the mechanisms regulating specific host-pathogen interactions that promote bacterial persistence is necessary to develop new approaches to RUTI diagnosis and treatment.
Results: LC2 and EC73 UPEC strains were collected from patients with RUTIs. E. coli CFT073 and K-12 MG1655 were used as reference strains. UPEC displayed phenotypic profiles like those of the general E. coli population. The pan-genome analysis revealed that LC2 harbored many unique genes encoding several different functions such as intracellular trafficking and secretion, and vesicular transport. Contrarily, EC73 was the strain with the lowest number of unique genes involved in replication, recombination, repair and cell wall/membrane/envelope biogenesis. LC2 and EC73 exhibited the capacity to invade bladder monolayers efficiently and to colonize the gut of Caenorhabditis elegans, with LC2 being significantly more virulent than EC73. T24 cells infected with EC73 and LC2 strains exhibited significantly increased mRNA levels of IL-6, IL-8,…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.